In addition, no correlation was found between PNPLA3 I148M and serum LPC levels in NAFLD patients in a study on the effect of PNPLA3 single nucleotide polymorphisms on serum lipidomics in NAFLD patients [25]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.